- Report
- August 2024
- 146 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- May 2024
- 296 Pages
Global
From €3327EUR$3,500USD£2,795GBP
€4753EUR$5,000USD£3,993GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- June 2024
- 184 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- August 2024
- 200 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- May 2024
United States
From €2709EUR$2,850USD£2,276GBP
- Report
- May 2024
Latin America
From €9031EUR$9,500USD£7,587GBP
- Report
- March 2025
- 416 Pages
Global
From €6650EUR$6,995USD£5,587GBP
- Report
- December 2024
- 424 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- August 2024
- 148 Pages
Global
From €2842EUR$2,990USD£2,388GBP
- Report
- July 2024
- 124 Pages
Global
From €4421EUR$4,650USD£3,714GBP
- Report
- November 2024
- 177 Pages
Global
From €3969EUR$4,175USD£3,334GBP
- Report
- October 2024
- 191 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 197 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 186 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 196 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 192 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- May 2024
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- January 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- January 2025
- 293 Pages
Global
From €4753EUR$5,000USD£3,993GBP

The Immunodiagnostic market is a segment of the In Vitro Diagnostics (IVD) industry. It is focused on the development and production of tests that use antibodies to detect the presence of a specific antigen in a sample. These tests are used to diagnose a wide range of diseases, including cancer, autoimmune disorders, and infectious diseases. Immunodiagnostics are also used to monitor the effectiveness of treatments and to assess the risk of developing certain diseases.
Immunodiagnostics are typically performed in a laboratory setting, using a variety of techniques such as enzyme-linked immunosorbent assays (ELISA), immunofluorescence, and immunohistochemistry. These tests are often used in combination with other diagnostic methods, such as imaging and molecular diagnostics, to provide a more comprehensive diagnosis.
Some of the major companies in the Immunodiagnostic market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more